603439 logo

Guizhou Sanli Pharmaceutical Co.,Ltd Stock Price

SHSE:603439 Community·CN¥4.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603439 Share Price Performance

CN¥0
-13.20 (-100.00%)
CN¥0
-13.20 (-100.00%)
Price CN¥0

603439 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

2 Risks
1 Reward

Guizhou Sanli Pharmaceutical Co.,Ltd Key Details

CN¥1.7b

Revenue

CN¥533.9m

Cost of Revenue

CN¥1.2b

Gross Profit

CN¥1.0b

Other Expenses

CN¥160.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 18, 2026
0.40
69.24%
9.26%
52.2%
View Full Analysis

About 603439

Founded
1995
Employees
2852
CEO
Qianfan Zhang
WebsiteView website
www.gz-sanli.com

Guizhou Sanli Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the plantation, research, development, production, and sale of pharmaceutical products in China. The company offers respiratory system, tonic, gynecological, and orthopedic medications, as well as cardiovascular and cerebrovascular drugs, and other medicines. It also provides products in various dosage forms, including sprays, granules, capsules, pills, tablets, medicated wines, and ointments. The company was founded in 1995 and is based in Anshun, China.

Recent 603439 News & Updates

Recent updates

No updates